Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Singing away the ring: new training aims to silence tinnitus without drugs

NCT ID NCT06880367

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a 5-week audio-proprio-phonatory training program can reduce the daily-life disability caused by chronic tinnitus. 56 adults with tinnitus will either receive the training or not, and researchers will use brain wave recordings (EEG) and questionnaires to measure changes. The training involves group workshops and self-led exercises where patients use their own voice to mask or inhibit the ringing in their ears.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
audio-proprio-phonatory reinforcement training (behavioral intervention)
What this could lead to
If it works, this could offer a drug-free, self-administered technique to help people manage chronic tinnitus and reduce its impact on daily life.
What could go wrong
This is a small, early-stage study (56 people) with no blinding or placebo control. The training requires active participation and may not work for everyone. Results rely on subjective questionnaires.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 56 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2025

Expected to finish

Sep 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 84 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Person who agreed to participate in the study and gave consent * Aged ≥ 18 years and \< 85 years * Suffering from subjective tinnitus for more than 3 months * Have a score on the THI questionnaire taken at T0 greater than or equal to 38 * Be equipped with a smartphone compatible with the Siopi application and a computer connection for videoconference sessions * Have answered the questionnaires on the Siopi application: THI, VAS-D and associated questions and insomnia severity index * Have committed to diligently following the study protocol, including independent training * Have agreed not to take other new treatments for tinnitus throughout the duration of the study * Able to understand and carry out assessment instructions. Exclusion Criteria: * Patient suffering from objective tinnitus * Current port of white noise generators * Patient having consulted phoniatrics more than twice or having participated in more than two sound-mediated workshop sessions * Bilateral hearing loss \> 40 dB uncorrected on an audiogram or having declared serious or severe hearing loss on Siopi questionnaire, with or without prosthetic correction * New therapy introduced less than 2 months ago * Psychatric disorders causing auditory hallucinations * Protected person (under guardianship or curatorship) * Person under judicial protection * Person deprived of liberty * Person not affiliated to a social security system * Pregnant or breastfeeding woman * Person participating in a drug study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Tinnitus, subjective are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CHU Orleans

    RECRUITING

    Orléans, 45067, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.